Atara Biotherapeutics and Pierre Fabre Laboratories Release Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

Atara Biotherapeutics and Pierre Fabre Laboratories Publish Data from Phase 3 ALLELE Tab-cel® Trial in The Lancet Oncology” Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, and Pierre Fabre Laboratories, a global player in oncology responsible for the…

Read MoreAtara Biotherapeutics and Pierre Fabre Laboratories Release Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

Solidsoft Reply Takes Charge of the Migration for Finland’s National Drug Verification System

Solidsoft Reply, a subsidiary of the Reply Group specializing in crafting business solutions on the Microsoft Azure cloud, has successfully migrated Finland’s National Medicines Verification System to its National Blueprint solution. Designed to comply with the EU Falsified Medicines Directive…

Read MoreSolidsoft Reply Takes Charge of the Migration for Finland’s National Drug Verification System

Kindeva Drug Delivery Establishes New Global Business Unit for Analytical Services

Kindeva Drug Delivery (Kindeva), a prominent player in drug and medical device combination products globally, has unveiled the expansion of its analytical services, establishing a new global business unit. This unit is dedicated to providing integrated and standalone analytical support…

Read MoreKindeva Drug Delivery Establishes New Global Business Unit for Analytical Services

Ally Health Collaborates with Acacium Group to Transform Technology-Enabled Clinical Care at Home

Pioneering health tech platform Ally Health and leading global healthcare delivery partner Acacium Group have joined forces in a new partnership aimed at revolutionizing the delivery of community care. With over 70% of medical decisions requiring follow-up appointments, Ally Health’s…

Read MoreAlly Health Collaborates with Acacium Group to Transform Technology-Enabled Clinical Care at Home

Align Technology Ranks Among the Top 300 Global Organizations Awarded U.S. Patents in 2023

Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company specializing in the design, manufacturing, and sale of the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, proudly announces…

Read MoreAlign Technology Ranks Among the Top 300 Global Organizations Awarded U.S. Patents in 2023

New independent clinical study shows safety and efficacy of GC Aesthetics’ PERLE breast implants

-GC Aesthetics® (GCA), a privately held medical technology company providing aesthetic and reconstructive solutions to the global healthcare market, We announced that our implant, PERLE™, was recently featured in an independently peer-reviewed paper published in the Aesthetic Surgery Journal Open…

Read MoreNew independent clinical study shows safety and efficacy of GC Aesthetics’ PERLE breast implants

ObjectiveHealth Announces Strategic Growth Investment from Vitruvian Partners

ObjectiveHealth, a leading integrated specialty research network and technology company, announced today that it has secured a strategic growth investment from Vitruvian Partners, a leading global growth-focused investment firm. ObjectiveHealth is an innovator in clinical research, seamlessly integrating clinical trials…

Read MoreObjectiveHealth Announces Strategic Growth Investment from Vitruvian Partners

Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

 a digital health technology company that delivers precision measurement of mental health through AI, today announced its inclusion in the U.S. Food and Drug Administration (FDA) Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program. Under the program,…

Read MoreDeliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

Isaac Health Raises $5.7M to End Dementia Care Deserts and Build the Future of Brain Health Care Delivery

Oversubscribed Seed round led by Meridian Street Capital and B Capital Isaac Health, a digital health company emerging as a national leader for brain health, announced today the successful completion of its oversubscribed $5.7 million Seed round. The round was…

Read MoreIsaac Health Raises $5.7M to End Dementia Care Deserts and Build the Future of Brain Health Care Delivery

New Independent Clinical Study Demonstrates Safety and Effectiveness of GC Aesthetics PERLE Breast Implant

GC Aesthetics® (GCA), a privately held medical technology company providing aesthetic and reconstructive solutions for global healthcare markets, is proud to announce that its PERLE™ breast implant is featured in a recent independent peer-reviewed article in the Aesthetic Surgery Journal…

Read MoreNew Independent Clinical Study Demonstrates Safety and Effectiveness of GC Aesthetics PERLE Breast Implant